Literature DB >> 27070700

Long Noncoding RNAs in Cancer Pathways.

Adam M Schmitt1, Howard Y Chang2.   

Abstract

Genome-wide cancer mutation analyses are revealing an extensive landscape of functional mutations within the noncoding genome, with profound effects on the expression of long noncoding RNAs (lncRNAs). While the exquisite regulation of lncRNA transcription can provide signals of malignant transformation, we now understand that lncRNAs drive many important cancer phenotypes through their interactions with other cellular macromolecules including DNA, protein, and RNA. Recent advancements in surveying lncRNA molecular mechanisms are now providing the tools to functionally annotate these cancer-associated transcripts, making these molecules attractive targets for therapeutic intervention in the fight against cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27070700      PMCID: PMC4831138          DOI: 10.1016/j.ccell.2016.03.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  168 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.

Authors:  John L Rinn; Michael Kertesz; Jordon K Wang; Sharon L Squazzo; Xiao Xu; Samantha A Brugmann; L Henry Goodnough; Jill A Helms; Peggy J Farnham; Eran Segal; Howard Y Chang
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 3.  The disappearing Barr body in breast and ovarian cancers.

Authors:  Gayle J Pageau; Lisa L Hall; Shridar Ganesan; David M Livingston; Jeanne B Lawrence
Journal:  Nat Rev Cancer       Date:  2007-07-05       Impact factor: 60.716

4.  Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Authors:  George A Calin; Chang-gong Liu; Manuela Ferracin; Terry Hyslop; Riccardo Spizzo; Cinzia Sevignani; Muller Fabbri; Amelia Cimmino; Eun Joo Lee; Sylwia E Wojcik; Masayoshi Shimizu; Esmerina Tili; Simona Rossi; Cristian Taccioli; Flavia Pichiorri; Xiuping Liu; Simona Zupo; Vlad Herlea; Laura Gramantieri; Giovanni Lanza; Hansjuerg Alder; Laura Rassenti; Stefano Volinia; Thomas D Schmittgen; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  Cancer Cell       Date:  2007-09       Impact factor: 31.743

5.  DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Authors:  M J Bussemakers; A van Bokhoven; G W Verhaegh; F P Smit; H F Karthaus; J A Schalken; F M Debruyne; N Ru; W B Isaacs
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

6.  MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.

Authors:  Ping Ji; Sven Diederichs; Wenbing Wang; Sebastian Böing; Ralf Metzger; Paul M Schneider; Nicola Tidow; Burkhard Brandt; Horst Buerger; Etmar Bulk; Michael Thomas; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

7.  Activation of p53 by MEG3 non-coding RNA.

Authors:  Yunli Zhou; Ying Zhong; Yingying Wang; Xun Zhang; Dalia L Batista; Roger Gejman; Peter J Ansell; Jing Zhao; Catherine Weng; Anne Klibanski
Journal:  J Biol Chem       Date:  2007-06-13       Impact factor: 5.157

8.  Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

Authors:  Wenqiang Yu; David Gius; Patrick Onyango; Kristi Muldoon-Jacobs; Judith Karp; Andrew P Feinberg; Hengmi Cui
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

9.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21.

Authors:  Ian Tomlinson; Emily Webb; Luis Carvajal-Carmona; Peter Broderick; Zoe Kemp; Sarah Spain; Steven Penegar; Ian Chandler; Maggie Gorman; Wendy Wood; Ella Barclay; Steven Lubbe; Lynn Martin; Gabrielle Sellick; Emma Jaeger; Richard Hubner; Ruth Wild; Andrew Rowan; Sarah Fielding; Kimberley Howarth; Andrew Silver; Wendy Atkin; Kenneth Muir; Richard Logan; David Kerr; Elaine Johnstone; Oliver Sieber; Richard Gray; Huw Thomas; Julian Peto; Jean-Baptiste Cazier; Richard Houlston
Journal:  Nat Genet       Date:  2007-07-08       Impact factor: 38.330

10.  A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Authors:  Sascha Trapp; Mark S Parcells; Jeremy P Kamil; Daniel Schumacher; B Karsten Tischer; Pankaj M Kumar; Venugopal K Nair; Nikolaus Osterrieder
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  1193 in total

Review 1.  RNA Structural Differentiation: Opportunities with Pattern Recognition.

Authors:  Christopher S Eubanks; Amanda E Hargrove
Journal:  Biochemistry       Date:  2018-12-18       Impact factor: 3.162

2.  APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production.

Authors:  Feng-Wei Wang; Chen-Hui Cao; Kai Han; Yong-Xiang Zhao; Mu-Yan Cai; Zhi-Cheng Xiang; Jia-Xing Zhang; Jie-Wei Chen; Li-Ping Zhong; Yong Huang; Su-Fang Zhou; Xiao-Han Jin; Xin-Yuan Guan; Rui-Hua Xu; Dan Xie
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

3.  Novel Long Non-coding RNA lncAMPC Promotes Metastasis and Immunosuppression in Prostate Cancer by Stimulating LIF/LIFR Expression.

Authors:  Wei Zhang; Xiaolei Shi; Rui Chen; Yasheng Zhu; Shihong Peng; Yifan Chang; Xinwen Nian; Guang'an Xiao; Ziyu Fang; Yaoming Li; Zhexu Cao; Lin Zhao; Guang Liu; Yinghao Sun; Shancheng Ren
Journal:  Mol Ther       Date:  2020-06-15       Impact factor: 11.454

4.  A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.

Authors:  Manjari Kiran; Ajay Chatrath; Xiwei Tang; Daniel Macrae Keenan; Anindya Dutta
Journal:  Mol Neurobiol       Date:  2018-11-03       Impact factor: 5.590

5.  LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P.

Authors:  Boon-Shing Tan; Min-Chi Yang; Shaifali Singh; Yu-Chi Chou; Hsin-Yi Chen; Ming-Yang Wang; Yi-Ching Wang; Ruey-Hwa Chen
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

Review 6.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 7.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

8.  Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.

Authors:  Jin-Feng Huang; Hong-Yue Jiang; Hui Cai; Yan Liu; Yi-Qing Zhu; Sha-Sha Lin; Ting-Ting Hu; Tian-Tian Wang; Wen-Jun Yang; Bang Xiao; Shu-Han Sun; Li-Ye Ma; Hui-Rong Yin; Fang Wang
Journal:  Oncogene       Date:  2019-01-14       Impact factor: 9.867

9.  Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.

Authors:  Rui Wang; Bin Zheng; Hongyan Liu; Xiuxian Wan
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

10.  Long noncoding RNA SYISL regulates myogenesis by interacting with polycomb repressive complex 2.

Authors:  Jian Jun Jin; Wei Lv; Pan Xia; Zai Yan Xu; An Dai Zheng; Xiao Jing Wang; Shan Shan Wang; Rui Zeng; Hong Mei Luo; Guo Liang Li; Bo Zuo
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.